nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer’s Association
|
|
|
2006 |
2 |
4 |
p. A11-A16 nvt p. |
artikel |
2 |
Alzheimer’s Association Medical and Scientific Advisory Council
|
|
|
2006 |
2 |
4 |
p. A6- 1 p. |
artikel |
3 |
Alzheimer’s Association Update
|
|
|
2006 |
2 |
4 |
p. 334- 1 p. |
artikel |
4 |
Author Index to Volume 2
|
|
|
2006 |
2 |
4 |
p. 330-331 2 p. |
artikel |
5 |
Challenges to demonstrating disease-modifying effects in Alzheimer’s disease clinical trials
|
Cummings, Jeffrey L. |
|
2006 |
2 |
4 |
p. 263-271 9 p. |
artikel |
6 |
Commentary on “Challenges to demonstrating disease-modifying effects in Alzheimer’s disease clinical trials”
|
Aisen, Paul S. |
|
2006 |
2 |
4 |
p. 272-274 3 p. |
artikel |
7 |
Commentary on “Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery.” Atorvastatin’s effect in Alzheimer’s dementia (LEADe) study
|
Hey-Hadavi, Judith |
|
2006 |
2 |
4 |
p. 282-283 2 p. |
artikel |
8 |
Commentary on “Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery.” Pleiotropic approaches to Alzheimer’s and other diseases of aging
|
Cole, Greg M. |
|
2006 |
2 |
4 |
p. 284-286 3 p. |
artikel |
9 |
Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer℉s disease.” Biochemical biomarkers of late-life dementia
|
Clark, Christopher M. |
|
2006 |
2 |
4 |
p. 287-293 7 p. |
artikel |
10 |
Commentary on “Perspective on a pathogenesis and treatment of Alzheimer’s disease.” Therapeutic strategies for Alzheimer’s disease: The need for a new era of innovation
|
Smith, Mark A. |
|
2006 |
2 |
4 |
p. 294-295 2 p. |
artikel |
11 |
Common threads in neurodegenerative disorders of aging
|
Flint Beal, M. |
|
2006 |
2 |
4 |
p. 322-326 5 p. |
artikel |
12 |
Contents
|
|
|
2006 |
2 |
4 |
p. A3- 1 p. |
artikel |
13 |
Contents
|
|
|
2006 |
2 |
4 |
p. A4- 1 p. |
artikel |
14 |
Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery
|
Schenk, Dale |
|
2006 |
2 |
4 |
p. 275-281 7 p. |
artikel |
15 |
Dementia diagnosis, treatment, and research with American Indians
|
Weiner, Myron F. |
|
2006 |
2 |
4 |
p. 327-329 3 p. |
artikel |
16 |
Editorial board
|
|
|
2006 |
2 |
4 |
p. A5- 1 p. |
artikel |
17 |
Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer’s disease patients
|
Huey, Edward D. |
|
2006 |
2 |
4 |
p. 314-321 8 p. |
artikel |
18 |
Independent contributions of neural and “higher-order” deficits to symptoms in Alzheimer’s disease: A latent variable modeling approach
|
Tractenberg, Rochelle E. |
|
2006 |
2 |
4 |
p. 303-313 11 p. |
artikel |
19 |
Information for Authors
|
|
|
2006 |
2 |
4 |
p. A7-A9 nvt p. |
artikel |
20 |
Key Word Index to Volume 2
|
|
|
2006 |
2 |
4 |
p. 332-333 2 p. |
artikel |
21 |
Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: A combined neuropsychological and voxel based morphometry study
|
Trivedi, Mehul A. |
|
2006 |
2 |
4 |
p. 296-302 7 p. |
artikel |
22 |
Subscriber information page
|
|
|
2006 |
2 |
4 |
p. A2- 1 p. |
artikel |